Day: January 6, 2025

GCC Closes Strategic Aggregates Acquisitions

Written by Customer Service on January 6, 2025. Posted in Mergers And Acquisitions.

CHIHUAHUA, Mexico, Jan. 06, 2025 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, today announced the acquisition of three pure-play aggregates operations in Texas, for approximately US$100 million, subject to potential customary post-closing adjustments. These assets add more than 4 million tons of annual production capacity and more than 50 years of proven, high-quality reserves to GCC’s portfolio. The acquisitions strengthen GCC’s presence in the Amarillo, Midland-Odessa, Dallas-Fort Worth, and San Antonio, Texas, markets, key regions for growth and infrastructure development. “These acquisitions mark an important milestone in our strategy to expand into key growth markets,” said Enrique Escalante, GCC’s CEO. “This move not only expands our product...

Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 6, 2025. Posted in Public Companies.

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 8:15 a.m. PT. A live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the...

Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment

Written by Customer Service on January 6, 2025. Posted in Mergers And Acquisitions.

Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: NARI) for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion. Inari, which was founded in 2011, will bring a leading peripheral vascular position in the fast-growing segment of venous thromboembolism (VTE) to Stryker. Inari’s innovative product portfolio is highly complementary to Stryker’s Neurovascular business and includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. Each year, VTE impacts up to 900,000 lives in the United States,...

Nobel Resources Signs Option Agreements to Acquire 100% Interest in Chilean Copper Portfolio in Antofagasta Region, Chile

Written by Customer Service on January 6, 2025. Posted in Mergers And Acquisitions.

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX – V: NBLC) (the “Company” or “Nobel”) is pleased to announce it has entered into binding agreements pursuant to which it can acquire a 100% interest in four separate copper projects (collectively, the “Projects”), namely Cuprita, Janett, Pampa Austral and Anais (the “Transaction”). The Projects are being acquired by Nobel’s wholly owned Chilean subsidiary, Mantos Grandes Resources Chile SpA (“Mantos”). Mantos is acquiring the Cuprita Project claims pursuant to an option agreement dated January 3, 2025 between Mantos and a group of private Chilean companies listed below. The Cuprita Project is the most advanced Project being acquired pursuant the Transaction and will be the Company’s principal asset following the closing of the Transaction. Cuprita is a highly...

Sodexo – Monthly disclosure on share capital and voting rights on December 31, 2024

Written by Customer Service on January 6, 2025. Posted in Public Companies.

Regulated informationIssy-les-Moulineaux, January 6, 2025 Monthly disclosure on share capital and voting rights Pursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights **December 31, 2024147,454,887216,692,568218,518,081* Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights. ** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having...

ARGAN: HALF-YEAR ASSESSMENT LIQUIDITY CONTRACT WITH ODDO (H2 2024)

Written by Customer Service on January 6, 2025. Posted in Public Companies.

Press release – Neuilly-sur-Seine, Monday, January 6, 2025 – 5.45 pm Half-year assessment liquidity contract with Oddo Under the liquidity contract between ARGAN and NATIXIS ODDO BHF, on December 31, 2024, the following resources appeared in the liquidity account:24,944 ARGAN shares €394,746.84As a reminder, on June 30, 2024, the following resources appeared on the liquidity account:19,588 ARGAN shares €702,509.84Over the period from 07/01/2024 to 12/31/2024, were executed:2,591 purchase transactions 2,565 sales transactionsOver this same period, the volumes traded represented:101,196 shares and 7,092,698.7 euros for purchase 95,840 shares and 6,784,935.9 euros for sale2025 financial calendar (Publication of the press release after closing of the stock exchange)January 16: Annual results 2024March 20: General...

Nexity: Monthly disclosure of the total number of voting rights and shares composing the share capital – 31 December 2024

Written by Customer Service on January 6, 2025. Posted in Public Companies.

NEXITYSociété anonymeau capital de 280 648 620 eurosSiège Social : 19, rue de Vienne – TSA 5002975801 PARIS Cedex 08444 346 795 RCS Paris Monthly disclosure of the total numberof voting rights and shares composing the share capital in accordance with Articles L. 233-8-II of the French Commercial Code and 223-16 of the General Regulation of the Autorité des Marchés FinanciersInformation cut-off date Total numberof shares Net total number ofvoting rights31 December 202456,129,724Total gross 56,129,724Net total 55,755,840* Net total = Total number of voting rights attached to the shares – shares without voting rights Paris, 6 January 2025Attachment2025_01_06 – Monthly disclosure of the total number of voting rights and shares – December 2024

BIC: Half-Year liquidity contract statement

Written by Customer Service on January 6, 2025. Posted in Public Companies.

SOCIETE BIC Half-Year liquidity contract statement Clichy, France – January 6, 2025 Under the liquidity contract entered into between SOCIETE BIC and NATIXIS ODDO BHF, the following resources appeared on the liquidity account as of 31 December 2024:12,955 shares €2,583,022.41Is it reminded that, at the time of implementation of the liquidity contract, the following assets appeared:13,169 shares €2,390,514.77From July 1 to December 31, 2024 the following transactions were negotiated:2,707 purchases 2,560 salesDuring the same period, the traded volume amounted to:259,490 shares for €15,834,547.10 purchases 276,398 shares for €16,851,148.58 salesThe implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted...

Disclosure of transactions in on shares from December 30th, 2024 to January 03rd, 2025

Written by Customer Service on January 6, 2025. Posted in Public Companies.

Nanterre, January 06th, 2025 Disclosure of transactions in on shares from December 30th, 2024 to January 03rd, 2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 09, 2024, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out From December 30th ,2024 to January 03rd, 2025: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 30/12/2024 FR0000125486 70 236 98,981838 XPARVINCI 30/12/2024 FR0000125486 29 920 98,981854 CEUXVINCI 30/12/2024 FR0000125486 9...

Nexity: Half-year liquidity contract statement – 31 December 2024

Written by Customer Service on January 6, 2025. Posted in Public Companies.

LIQUIDITY CONTRACT PRESS RELEASE Paris, 6 January 2025, 5.45 pm CESTHALF-YEAR LIQUIDITY CONTRACT STATEMENT ON 31 DECEMBER 2024 Under the liquidity contract signed between Nexity and Rothschild Martin Maurel, the following assets were booked to the liquidity account on 31 December 2024:0 (zero) share €3,629,606In the second half of 2024, a total of:1,984,940 shares were purchased for €23,767,085 2,154,940 shares were sold for €25,533,260As a reminder:On the previous half-year statement on 30 June 2024, the following resources appeared on the liquidity account:170,000 shares €1,863,430 In the first half of 2024, a total of:746,638 shares were purchased for €8,578,525 810,026 shares were sold for €9,249,986 On 2 May 2024, date of the implementation of the liquidity contract with Rothschild Martin Maurel,...

Day: January 6, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice